vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
CareTrust REIT, Inc. is the larger business by last-quarter revenue ($134.9M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs -38.1%, a 120.6% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 20.2%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 24.8%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
CTRE vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $83.1M |
| Net Profit | $111.3M | $-31.6M |
| Gross Margin | — | 64.9% |
| Operating Margin | — | -4.1% |
| Net Margin | 82.5% | -38.1% |
| Revenue YoY | 55.1% | 20.2% |
| Net Profit YoY | 113.5% | -27.9% |
| EPS (diluted) | $0.52 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $134.9M | $76.4M | ||
| Q3 25 | $132.4M | $83.3M | ||
| Q2 25 | $112.5M | $79.2M | ||
| Q1 25 | $96.6M | $69.2M | ||
| Q4 24 | $86.9M | $68.2M | ||
| Q3 24 | $77.4M | $58.4M | ||
| Q2 24 | $68.9M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $111.3M | $-29.8M | ||
| Q3 25 | $74.9M | $-21.4M | ||
| Q2 25 | $68.5M | $-19.6M | ||
| Q1 25 | $65.8M | $-24.7M | ||
| Q4 24 | $52.1M | $-18.9M | ||
| Q3 24 | $33.4M | $-21.0M | ||
| Q2 24 | $10.8M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | — | 60.6% | ||
| Q3 25 | — | 64.8% | ||
| Q2 25 | — | 65.4% | ||
| Q1 25 | — | 63.9% | ||
| Q4 24 | — | 64.0% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | — | -40.6% | ||
| Q3 25 | 58.1% | -27.8% | ||
| Q2 25 | 61.3% | -28.0% | ||
| Q1 25 | — | -39.7% | ||
| Q4 24 | — | -28.9% | ||
| Q3 24 | 43.0% | -38.4% | ||
| Q2 24 | 15.1% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 82.5% | -39.1% | ||
| Q3 25 | 56.6% | -25.7% | ||
| Q2 25 | 60.9% | -24.7% | ||
| Q1 25 | 68.1% | -35.8% | ||
| Q4 24 | 60.0% | -27.6% | ||
| Q3 24 | 43.2% | -35.9% | ||
| Q2 24 | 15.6% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.52 | $-0.54 | ||
| Q3 25 | $0.35 | $-0.38 | ||
| Q2 25 | $0.35 | $-0.35 | ||
| Q1 25 | $0.35 | $-0.45 | ||
| Q4 24 | $0.30 | $-0.34 | ||
| Q3 24 | $0.21 | $-0.40 | ||
| Q2 24 | $0.07 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $245.6M |
| Total DebtLower is stronger | $894.2M | $51.7M |
| Stockholders' EquityBook value | $4.0B | $347.7M |
| Total Assets | $5.1B | $487.1M |
| Debt / EquityLower = less leverage | 0.22× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $198.0M | $286.5M | ||
| Q3 25 | $712.5M | $294.3M | ||
| Q2 25 | $306.1M | $302.7M | ||
| Q1 25 | $26.5M | $316.2M | ||
| Q4 24 | $213.8M | $333.7M | ||
| Q3 24 | $377.1M | $196.8M | ||
| Q2 24 | $495.1M | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | $894.2M | $51.6M | ||
| Q3 25 | $893.8M | $51.6M | ||
| Q2 25 | $1.2B | $51.5M | ||
| Q1 25 | $822.1M | $51.5M | ||
| Q4 24 | $396.9M | $51.5M | ||
| Q3 24 | $396.7M | $51.4M | ||
| Q2 24 | $671.1M | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $4.0B | $365.9M | ||
| Q3 25 | $4.0B | $380.3M | ||
| Q2 25 | $3.3B | $385.8M | ||
| Q1 25 | $2.9B | $389.2M | ||
| Q4 24 | $2.9B | $402.2M | ||
| Q3 24 | $2.4B | $241.2M | ||
| Q2 24 | $1.9B | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $5.1B | $508.1M | ||
| Q3 25 | $5.1B | $511.5M | ||
| Q2 25 | $4.7B | $513.1M | ||
| Q1 25 | $3.9B | $519.4M | ||
| Q4 24 | $3.4B | $534.0M | ||
| Q3 24 | $2.9B | $374.1M | ||
| Q2 24 | $2.7B | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | 0.22× | 0.14× | ||
| Q3 25 | 0.22× | 0.14× | ||
| Q2 25 | 0.35× | 0.13× | ||
| Q1 25 | 0.28× | 0.13× | ||
| Q4 24 | 0.14× | 0.13× | ||
| Q3 24 | 0.16× | 0.21× | ||
| Q2 24 | 0.35× | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $394.0M | $-10.3M | ||
| Q3 25 | $100.9M | $-6.6M | ||
| Q2 25 | $100.8M | $-15.0M | ||
| Q1 25 | $71.4M | $-17.0M | ||
| Q4 24 | $244.3M | $-32.4M | ||
| Q3 24 | $67.2M | $-18.8M | ||
| Q2 24 | $53.0M | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $-12.2M | ||
| Q3 25 | — | $-9.5M | ||
| Q2 25 | — | $-17.8M | ||
| Q1 25 | — | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | -15.9% | ||
| Q3 25 | — | -11.4% | ||
| Q2 25 | — | -22.5% | ||
| Q1 25 | — | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 3.54× | — | ||
| Q3 25 | 1.35× | — | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.08× | — | ||
| Q4 24 | 4.68× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 4.92× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRE
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
